FR2319346A1 - Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole - Google Patents

Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole

Info

Publication number
FR2319346A1
FR2319346A1 FR7623355A FR7623355A FR2319346A1 FR 2319346 A1 FR2319346 A1 FR 2319346A1 FR 7623355 A FR7623355 A FR 7623355A FR 7623355 A FR7623355 A FR 7623355A FR 2319346 A1 FR2319346 A1 FR 2319346A1
Authority
FR
France
Prior art keywords
imidazole
benzimidazole
combination
product containing
inflammatory agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7623355A
Other languages
English (en)
French (fr)
Other versions
FR2319346B1 (enExample
Inventor
Robert Bruce Clark
Sergio Henrique Ferreira
Nariman Bomanshaw Mehta
Peter Brian Thorogood
Ralph Vinegar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2319346A1 publication Critical patent/FR2319346A1/fr
Application granted granted Critical
Publication of FR2319346B1 publication Critical patent/FR2319346B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7623355A 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole Granted FR2319346A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB3200575 1975-07-31
GB3200475 1975-07-31
GB2718476 1976-06-30

Publications (2)

Publication Number Publication Date
FR2319346A1 true FR2319346A1 (fr) 1977-02-25
FR2319346B1 FR2319346B1 (enExample) 1979-05-25

Family

ID=27258606

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7623355A Granted FR2319346A1 (fr) 1975-07-31 1976-07-30 Medicament comprenant une association d'un agent anti-inflammatoire et d'un imidazole ou d'un benzimidazole

Country Status (10)

Country Link
JP (1) JPS5218831A (enExample)
AU (1) AU1643776A (enExample)
DE (1) DE2634409A1 (enExample)
DK (1) DK345676A (enExample)
FR (1) FR2319346A1 (enExample)
IL (1) IL50174A0 (enExample)
LU (1) LU75513A1 (enExample)
NL (1) NL7608503A (enExample)
NZ (1) NZ181635A (enExample)
SE (1) SE7608611L (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045200A1 (en) * 1980-07-28 1982-02-03 The Upjohn Company Benzimidazoles and their pharmaceutical use
FR2488136A1 (fr) * 1980-08-05 1982-02-12 Italfarmaco Spa Composition pharmaceutique a base de salicylate d'imidazole
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
EP0449426A1 (en) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited A pharmaceutical composition

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives
DE3508665A1 (de) * 1985-03-12 1986-09-18 Hoechst Ag, 6230 Frankfurt Heterocyclische sulfide und ihre anwendung als immunmodulatoren
US5164406A (en) * 1988-06-02 1992-11-17 Bristol-Myers Squibb Co. Method for enhancing transdermal penetration and compositions useful therein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
UNLISTED DRUGS, 24, P.9C 1972 "LIPIDAZIL") *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0045200A1 (en) * 1980-07-28 1982-02-03 The Upjohn Company Benzimidazoles and their pharmaceutical use
FR2488136A1 (fr) * 1980-08-05 1982-02-12 Italfarmaco Spa Composition pharmaceutique a base de salicylate d'imidazole
EP0270316A3 (en) * 1986-12-04 1989-12-06 Pfizer Inc. Topical compositions comprising 1-substituted imidazoles and nsaids for treatment of acne
EP0449426A1 (en) * 1990-02-26 1991-10-02 Byrne Rynne Holdings Limited A pharmaceutical composition
US5156849A (en) * 1990-02-26 1992-10-20 Byrne Rynne Holdings Limited Pharmaceutical composition

Also Published As

Publication number Publication date
IL50174A0 (en) 1976-09-30
LU75513A1 (enExample) 1977-04-15
SE7608611L (sv) 1977-02-01
DK345676A (da) 1977-02-01
AU1643776A (en) 1978-02-02
FR2319346B1 (enExample) 1979-05-25
JPS5218831A (en) 1977-02-12
DE2634409A1 (de) 1977-02-17
NZ181635A (en) 1978-09-25
NL7608503A (nl) 1977-02-02

Similar Documents

Publication Publication Date Title
US4016268A (en) Method of combatting gastric ulceration
IE37998B1 (en) Indole derivatives
GB1509979A (en) Pharmaceutical compositions containing aspirin or indomethacin
SE8304003D0 (sv) Medicinsk komposition innehallande pirprofen
Derelanko et al. Carbenoxolone sodium protects rat gastric mucosa against ethanol-induced necrosis
ES8307494A1 (es) "un procedimiento para preparar una composicion farmaceutica que proporciona un efecto anti-inflamatorio y analgesico junto con un dano gastrico minimizado".
JPS5234935A (en) Medicinal composition
SE8002322L (sv) Medel for behandling av inflammatoriska tarmsjukdomar
SE7413548L (enExample)
JPS5896036A (ja) 新ナフタレン誘導体の製法
ATE22879T1 (de) Pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
JPS52108028A (en) Remedies for dysacousis
FR2318649A1 (fr) Medicament pour le traitement des rhumatismes et cancers
ES8302623A1 (es) "procedimiento para la preparacion del acido (2',4'-difluoro-4-bifenil)-oxipropionico".
HUT35519A (en) Process for producing of anelgetic medical preparatives
KR830009776A (ko) 세포 보호 유도방법
GB1351853A (en) Salicylate derivative
JPS577422A (en) Crocosmia aurea "plach"
JPS61134315A (ja) 解熱鎮痛剤
GB1239266A (enExample)
ES8304932A1 (es) Un procedimiento para la preparacion de derivados de cistina".
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
FR2079568A6 (enExample)
FR2085730A1 (en) Salicylamide salts for oral administration

Legal Events

Date Code Title Description
ST Notification of lapse